De Sanctis V, Soliman A, Tzoulis P, et al. The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network: Oral glucose-lowering agents (GLAs) in β-thalassemia patients. Acta Biomed. 2022;93(2):e2022162. doi:10.23750/abm.v93i2.12056